Cognitive impairment and cerebral hypoperfusion in a CADASIL patient improved during administration of lomerizine.
Mizuno T, Kondo M, Ishigami N, Tamura A, Itsukage M, Koizumi H, Isayama R, Hosomi A, Nagakane Y, Tokuda T, Sugimoto E, Ushijima Y, Nakagawa M.
Mizuno T, et al. Among authors: itsukage m.
Clin Neuropharmacol. 2009 Mar-Apr;32(2):113-6. doi: 10.1097/WNF.0b013e31816c82a6.
Clin Neuropharmacol. 2009.
PMID: 19512965